- Home
- GILD vs PBR Comparison
GILD vs PBR Comparison
Compare GILD & PBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- PBR
- Stock Information
- Founded
- GILD 1987
- PBR 1953
- Country
- GILD United States
- PBR Brazil
- Employees
- GILD N/A
- PBR N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- PBR Oil & Gas Production
- Sector
- GILD Health Care
- PBR Energy
- Exchange
- GILD Nasdaq
- PBR Nasdaq
- Market Cap
- GILD 113.0B
- PBR 91.1B
- IPO Year
- GILD 1992
- PBR N/A
- Fundamental
- Price
- GILD $91.84
- PBR $13.72
- Analyst Decision
- GILD Buy
- PBR Strong Buy
- Analyst Count
- GILD 26
- PBR 8
- Target Price
- GILD $98.17
- PBR $18.28
- AVG Volume (30 Days)
- GILD 6.6M
- PBR 12.5M
- Earning Date
- GILD 02-11-2025
- PBR 02-26-2025
- Dividend Yield
- GILD 3.35%
- PBR 18.02%
- EPS Growth
- GILD N/A
- PBR N/A
- EPS
- GILD 0.10
- PBR 1.20
- Revenue
- GILD $28,299,000,000.00
- PBR $92,525,343,651.00
- Revenue This Year
- GILD $6.50
- PBR $0.70
- Revenue Next Year
- GILD $0.36
- PBR $1.66
- P/E Ratio
- GILD $908.39
- PBR $5.45
- Revenue Growth
- GILD 3.31
- PBR N/A
- 52 Week Low
- GILD $62.07
- PBR $12.55
- 52 Week High
- GILD $98.90
- PBR $17.91
- Technical
- Relative Strength Index (RSI)
- GILD 51.58
- PBR 54.82
- Support Level
- GILD $90.82
- PBR $13.38
- Resistance Level
- GILD $93.07
- PBR $13.74
- Average True Range (ATR)
- GILD 1.54
- PBR 0.26
- MACD
- GILD -0.03
- PBR 0.11
- Stochastic Oscillator
- GILD 56.28
- PBR 85.40
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About PBR Petroleo Brasileiro S.A.- Petrobras
Petrobras is a Brazil-based integrated energy company controlled by the Brazilian government. The company focuses on exploration and production of oil and gas in Brazilian offshore fields. Production in 2023 was 2.8 million barrels of oil equivalent a day (80% oil production), and reserves stood at 10.9 billion boe (85% oil). At end-2023, Petrobras operated 10 refineries in Brazil with capacity of 1.8 million barrels a day and distributes refined products and natural gas throughout Brazil.